找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c

[復(fù)制鏈接]
樓主: 調(diào)停
41#
發(fā)表于 2025-3-28 14:41:37 | 只看該作者
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
42#
發(fā)表于 2025-3-28 21:48:36 | 只看該作者
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
43#
發(fā)表于 2025-3-28 23:15:16 | 只看該作者
44#
發(fā)表于 2025-3-29 06:10:51 | 只看該作者
45#
發(fā)表于 2025-3-29 07:17:57 | 只看該作者
46#
發(fā)表于 2025-3-29 14:54:15 | 只看該作者
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
47#
發(fā)表于 2025-3-29 17:50:07 | 只看該作者
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
48#
發(fā)表于 2025-3-29 20:51:12 | 只看該作者
49#
發(fā)表于 2025-3-30 02:50:41 | 只看該作者
50#
發(fā)表于 2025-3-30 07:07:47 | 只看該作者
Overview: 978-3-642-83747-0978-3-642-83745-6
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 07:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
中山市| 和政县| 保山市| 岗巴县| 齐河县| 梧州市| 长丰县| 于都县| 木兰县| 印江| 疏附县| 景宁| 太和县| 长武县| 梅河口市| 两当县| 常山县| 通城县| 南和县| 镇雄县| 万全县| 香格里拉县| 钟山县| 攀枝花市| 河曲县| 饶平县| 南汇区| 洮南市| 平陆县| 江口县| 怀安县| 顺昌县| 惠来县| 贵州省| 民乐县| 安康市| 宁明县| 报价| 陕西省| 毕节市| 永安市|